On January 24, 2017, Data4Cure, Inc., announced a series of updates and new case studies using its Biomedical Intelligence® Cloud - a semantic data-driven discovery platform designed to continuously grow knowledge from a multitude of genomic, molecular and clinical data that are accumulating rapidly in the field. These updates were presented at a session hosted by Data4Cure at the Precision Medicine World Conference (PMWC) in Mountain View, California. The company's Biomedical Intelligence® Cloud now includes new tools for immune-oncology research, improved applications for mapping the molecular basis of disease, and a new multidimensional version of the company's molecular stratification engine. Data4Cure's platform is powered by CURIE™, a dynamic biomedical knowledge graph that is continuously updated with information dynamically extracted from a variety of data sources. Cross-referencing tens of thousands of datasets and bioinformatics analyses, literature, clinical trials, and external databases, CURIE provides immediate data-driven answers to over 100 million biomedical questions. "CURIE understands biology," said Janusz Dutkowski, Ph.D., CEO, Data4Cure, who chaired the PMWC session. "It combines advanced machine learning, systems biology, and semantic search capabilities providing a new way to make discoveries. Our platform allows biological and clinical researchers to leverage diverse datasets to discover relationships between entities in a molecular system, and uncover how these entities and relations are affected by the disease and environment, and how they respond to drug interventions." CURIE is used by multiple applications running on Data4Cure's Biomedical Intelligence Cloud.
Login Or Register To Read Full Story